EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Accessory hepatic vein recanalization: a viable approach in hepatic vein outflow tract obstruction

Yashwant Patidar iD, Vasav Tyagi iD, Navojit Chatterjee, Rajeev Ranjan, Amar Mukund, Manoj Kumar Sharma, Shiv Kumar Sarin

British Journal of Radiology · 2025

DOI: 10.1093/bjr/tqaf198 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift British Journal of Radiology, 2025. Verfasst von Yashwant Patidar und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Interventional Radiology, Institute of Liver and Biliary Sciences, New Delhi 110070, India. Hauptthemen laut MEDLINE: Hepatic Veins, Budd-Chiari Syndrome. Die Arbeit nennt 20 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To evaluate the mid- and long-term outcome of recanalization of accessory hepatic vein (AHV) secondary to hepatic venous outflow obstruction and to compare the mid- and long-term outcome and technical efficacy and safety of AHV recanalization with native hepatic vein (HV) recanalization in hepatic vein outflow tract obstruction (HVOTO) patients.

Methods

This retrospective observational study, conducted at a single-centre, evaluated the mid- and long-term outcomes of AHV recanalization compared to native HV recanalization in 170 HVOTO patients treated between January 2013 and October 2020.

Results

Patients were divided into 2 groups based on the type of recanalization performed: AHV (n = 26) and native HV (n = 144). Technical success was achieved in 100% of AHV cases and 95.8% of native HV cases. The primary patency rates at 1, 3, and 5 years were 95.9%, 92.3%, and 76.9% for AHV and 96.5%, 93%, and 79.1% for native HV, respectively. Significant improvements in liver stiffness, clinical symptoms, and hepatic function were observed post-intervention in both groups, with no significant differences in outcomes. Transplant-free survival rates at 1, 3, and 5 years were also comparable between groups.

Conclusion

This study demonstrates that AHV recanalization is a safe and effective alternative to native HV recanalization, providing comparable long-term outcomes. Advances in knowledge It offers a promising option for HVOTO patients with dominant AHV and extensive intrahepatic collaterals, further supporting its integration into the stepwise management of HVOTO.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatic VeinsBudd-Chiari SyndromeHumansRetrospective StudiesFemaleMaleMiddle AgedAdultTreatment OutcomeAged

Stichwörter der Autor:innen

Budd-Chiari syndromeaccessory hepatic veinhepatic veinhepatic venous outflow obstructionlong-term outcomes

Autor:innen und Institutionen

  • Department of Interventional Radiology, Institute of Liver and Biliary Sciences, New Delhi 110070, India.
  • Department of Hepatology, Institute of Liver & Biliary Sciences, New Delhi 110070, India.

ORCID-Profile: Yashwant Patidar, Vasav Tyagi

Zitieren

APA

Patidar, Y., Tyagi, V., Chatterjee, N., Ranjan, R., Mukund, A., Sharma, M. K., & Sarin, S. K. (2025). Accessory hepatic vein recanalization: a viable approach in hepatic vein outflow tract obstruction. British Journal of Radiology. https://doi.org/10.1093/bjr/tqaf198

Vancouver

Patidar Y, Tyagi V, Chatterjee N, Ranjan R, Mukund A, Sharma MK, et al. Accessory hepatic vein recanalization: a viable approach in hepatic vein outflow tract obstruction. British Journal of Radiology. 2025. doi:10.1093/bjr/tqaf198

BibTeX
@article{Patidar2025,
  author = {Patidar, Yashwant and Tyagi, Vasav and Chatterjee, Navojit and Ranjan, Rajeev and Mukund, Amar and Sharma, Manoj Kumar and Sarin, Shiv Kumar},
  title = {Accessory hepatic vein recanalization: a viable approach in hepatic vein outflow tract obstruction},
  journal = {British Journal of Radiology},
  year = {2025},
  doi = {10.1093/bjr/tqaf198}
}
Kostenlos starten →